The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

References

Page 1

	Year	Citations
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries The Lancet First YearHiv-1-infected PatientsEpidemiological TrendHealth EconomicsTreatment And Prevention	2006	1.1K
Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach James W. Curran, Haile T. Debas, Monisha Arya, Treatment GuidelinesHealthcare ProvisionHiv/aids CounsellingHealth PolicyTreatment And Prevention	2005	536
Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection Roy M. Gulick, Heather J. Ribaudo, Cecilia M. Shikuma, New England Journal of Medicine	2004	526
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment Laurent Ferradini, Arnaud Jeannin, Loretxu Pinoges, The Lancet Clinical EffectivenessHealth PolicyTreatment And PreventionRural HealthActive Antiretroviral Therapy	2006	449
Public health in the new era: improving health through collective action Robert Beaglehole, Ruth Bonita, Richard Horton, The Lancet Health ReformHealth PolicyHealth InterventionPublic Health SystemHealth Communication	2004	162
Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV‐Infected Antiretroviral‐Naive Subjects Joel E. Gallant, Allan Rodríguez, Winkler G. Weinberg, The Journal of Infectious Diseases	2005	146
Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa DART Virology Group and Trial Team AIDS	2006	130
British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005) Brian Gazzard HIV Medicine	2005	101
Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi Bulletin of the World Health Organization	2006	84
Indinavir/ritonavir‐based therapy in HIV‐1‐infected antiretroviral therapy‐naive patients: comparison of 800/100 mg and 400/100 mg twice daily Déborah Konopnicki, Bénédicte Poll, Kristel M. L. Crommentuyn, HIV Medicine	2005	69

Page 1